Platform communication and training

Ended Awarded Last action

Contract number
75F40122F80015
Awardee
Awarding agency
Obligated
$3,762,260

Award facts

Opportunity
  • RFQ1248262 Solicitation number
Contract value 100% obligated
$3,762,259.83 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
8(a) Sole Source
Competition
Full and Open Competition after exclusion of sources · 1 offer Multiple Award, Fair Opportunity
Pricing
Labor Hours
Place of performance
Takoma Park, MD 20901, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out P00007 -$1,951
Funding Only Action P00006 $9,500
Other Administrative Action P00005 · Incorporate hhsar clause 352.232-71 electronic submission of payment requests (FEB 2022) and FDA electronic invoicing and payment requirements - invoice… $0
Exercise an Option P00004 $1,824,942
Supplemental Agreement for work within scope P00003 $116,995
Supplemental Agreement for work within scope P00002 $23,500
Other Administrative Action P00001 $0
Original award $1,789,274

About this award

This federal contract award, valued at $3,762,259.83, was issued by the Food and Drug Administration (FDA) to A P Ventures, LLC, a woman-owned small disadvantaged business. The contract is a Delivery Order under the 8(a) STARS III Government-Wide Acquisition Contract (GWAC), which enables A P Ventures to provide customized IT services and solutions to federal agencies.

The contract is for Platform Communication and Training services, with a performance period ending on December 5, 2023. As an 8(a) Sole Source award, this contract leverages the 8(a) small business program to provide opportunities for socioeconomically disadvantaged firms. A P Ventures, certified as an 8(a) and Economically Disadvantaged Women-Owned Small Business (EDWOSB), specializes in IT modernization, software development, HR support, training, and project management, and has a strong track record of delivering diverse services to various federal agencies.

Quick answers

Who was awarded contract 75F40122F80015?

75F40122F80015 was awarded to A P Ventures, LLC by Food and Drug Administration (Department of Health and Human Services) on December 3, 2021.

How much is contract 75F40122F80015 worth?

The government has obligated $3,762,260 on 75F40122F80015.

Is contract 75F40122F80015 an order under another contract?

Yes. 75F40122F80015 is a delivery order under 47QTCB21D0325, a government wide acquisition contract (GWAC), on 8(a) STARS III (STARS III).

Was contract 75F40122F80015 competed?

The extent of competition for 75F40122F80015 was full and open competition after exclusion of sources. The government received 1 offer. It was set aside: 8(a) Sole Source.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award